Assessing the Feasibility of the One-Minute Sit-to-Stand Test as a Substitute for the Six-Minute Walk Test in Type 2 Diabetes: A Cross-Sectional Study
- PMID: 40565836
- PMCID: PMC12194420
- DOI: 10.3390/jcm14124088
Assessing the Feasibility of the One-Minute Sit-to-Stand Test as a Substitute for the Six-Minute Walk Test in Type 2 Diabetes: A Cross-Sectional Study
Abstract
Background/Objectives: Type 2 Diabetes Mellitus (T2DM) is associated with reduced exercise capacity. The six-minute-walk test (6MWT) is the gold standard submaximal test but has practical challenges, such as space constraint, time dependency and feasibility in clinical settings. This study aimed to determine if the one-minute sit-to-stand (1 min STS) test could predict walking capacity, as assessed by the 6MWT, among individuals with T2DM. Methods: Ninety-five individuals with T2DM participated in this cross-sectional study. Participants performed 1 min STS and 6MWT tests and completed the Arabic version of the International Physical Activity Questionnaire (Ar-IPAQ). Pearson's correlation was used to determine the correlation between one min STS and 6MWT tests. Multiple regression analysis was performed to determine whether 1 min STS predicted 6MWT while controlling for age, gender, BMI, IPAQ, and duration of diabetes. Results: Participants (mean age: 65.4 ± 6.4 years; 26.3% female; mean diabetes duration: 11.6 ± 6.4 years) demonstrated a significant moderate correlation between 1 min STS and 6MWT (r = 0.636, 95% CI [0.47-0.79], p < 0.001). Regression analysis revealed that the 1 min STS significantly predicted the 6MWT (β = 0.48, p < 0.001), regardless of age, gender, BMI, IPAQ, and duration of diabetes. Conclusions: The 1 min STS is inexpensive, simple to use, requires less space and materials that are widely available, and does not require experienced clinicians or researchers to administer. This test can be an alternative to the 6MWT for individuals with T2DM.
Keywords: diabetes mellitus; functional status; one-minute sit-to-stand test; physical activity; six-minute walk test.
Conflict of interest statement
The author declares no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript.
Figures
Similar articles
-
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3. Cochrane Database Syst Rev. 2016. PMID: 27030386 Free PMC article.
-
Validation of three functional tests against the 6-minute walk test in individuals with obesity.PeerJ. 2025 Jul 25;13:e19755. doi: 10.7717/peerj.19755. eCollection 2025. PeerJ. 2025. PMID: 40727245 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Less Time, Same Insight? Evaluating Short Functional Tests as Substitutes for the Six-Minute Walk Test and the Reliability and Validity of the 2MWT, 3MWT, and 1MSTS in Bariatric Surgery Candidates with Obesity.Healthcare (Basel). 2025 Aug 1;13(15):1883. doi: 10.3390/healthcare13151883. Healthcare (Basel). 2025. PMID: 40805920 Free PMC article.
-
Enzyme replacement therapy for late-onset Pompe disease.Cochrane Database Syst Rev. 2023 Dec 12;12(12):CD012993. doi: 10.1002/14651858.CD012993.pub2. Cochrane Database Syst Rev. 2023. PMID: 38084761 Free PMC article.
References
-
- Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
-
- Bloomgarden Z., Handelsman Y. Lipoproteins in Diabetes Mellitus. Springer; Berlin/Heidelberg, Germany: 2023. Diabetes Epidemiology and Its Implications; pp. 881–890.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials